| 吴 鹏,杨玲麟.调强放疗时代下的临床Ⅱ期鼻咽癌研究进展[J].中国肿瘤,2018,27(5):353-358. |
| 调强放疗时代下的临床Ⅱ期鼻咽癌研究进展 |
| Research Progress of Stage Ⅱ Nasopharyngeal Carcinoma in IMRT Era |
| 投稿时间：2018-03-16 |
| DOI：10.11735/j.issn.1004-0242.2018.05.A007 |
|
 |
| 中文关键词: 鼻咽癌 调强放疗 化疗 亚组分析 |
| 英文关键词:nasopharyngeal carcinoma intensity modulated radiation therapy(IMRT) chemotherapy subgroup analysis |
| 基金项目:国家自然科学基金青年科学基金项目（81201784） |
|
| 摘要点击次数: 2164 |
| 全文下载次数: 507 |
| 中文摘要: |
| 摘 要：鼻咽癌(NPC)的治疗已步入到了调强放射治疗(IMRT)时代，患者的治愈率及其生存质量(QOL)明显得到了提高，并且其不良反应也明显减轻。早期NPC的首选是放射治疗，但临床Ⅱ期NPC能否受益于放化疗综合治疗，目前尚有争议。另外，亚组分析发现，提高T2N1M0期患者的预后是临床Ⅱ期鼻咽癌研究进展中的瓶颈。 |
| 英文摘要: |
| Abstract：The treatment of nasopharyngeal carcinoma has entered in the era of intensity modulated radiation therapy(IMRT)，which improved cure rate and quality of life and reduced adverse effects significantly. Radiation therapy has become the standard treatment for early stage nasopharyngeal carcinoma，however，controversy still exists regarding whether stage Ⅱ patients can benefit from the combination of radiotherapy with chemotherapy. Besides，subgroup analyses have found that to improve the prognosis of patients in T2N1M0 stage is the key problem for research of stage Ⅱ nasopharyngeal carcinoma. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |